These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 25516122)
1. Interaction between the endocannabinoid and serotonergic system in the exhibition of head twitch response in four mouse strains. Ceci C; Proietti Onori M; Macrì S; Laviola G Neurotox Res; 2015 Apr; 27(3):275-83. PubMed ID: 25516122 [TBL] [Abstract][Full Text] [Related]
8. The effect of the sigma-1 receptor selective compound LS-1-137 on the DOI-induced head twitch response in mice. Malik M; Rangel-Barajas C; Mach RH; Luedtke RR Pharmacol Biochem Behav; 2016 Sep; 148():136-44. PubMed ID: 27397487 [TBL] [Abstract][Full Text] [Related]
9. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis. Darmani NA; Johnson JC Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052 [TBL] [Abstract][Full Text] [Related]
10. Effect of nicotine cessation on the central serotonergic systems in mice: involvement of 5-HT(2) receptors. Yasuda K; Suemaru K; Araki H; Gomita Y Naunyn Schmiedebergs Arch Pharmacol; 2002 Sep; 366(3):276-81. PubMed ID: 12172711 [TBL] [Abstract][Full Text] [Related]
11. Long-lasting alterations in 5-HT2A receptor after a binge regimen of methamphetamine in mice. Chiu HY; Chan MH; Lee MY; Chen ST; Zhan ZY; Chen HH Int J Neuropsychopharmacol; 2014 Oct; 17(10):1647-58. PubMed ID: 24763081 [TBL] [Abstract][Full Text] [Related]
12. A genetic screen for mouse mutations with defects in serotonin responsiveness. Weiss KC; Kim DY; Pawson CT; Cordes SP Brain Res Mol Brain Res; 2003 Jul; 115(2):162-72. PubMed ID: 12877987 [TBL] [Abstract][Full Text] [Related]
13. The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice. Russo R; Loverme J; La Rana G; Compton TR; Parrott J; Duranti A; Tontini A; Mor M; Tarzia G; Calignano A; Piomelli D J Pharmacol Exp Ther; 2007 Jul; 322(1):236-42. PubMed ID: 17412883 [TBL] [Abstract][Full Text] [Related]
15. Nicotine attenuates DOI-induced head-twitch response in mice: implications for Tourette syndrome. Tizabi Y; Russell LT; Johnson M; Darmani NA Prog Neuropsychopharmacol Biol Psychiatry; 2001 Oct; 25(7):1445-57. PubMed ID: 11513358 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological modulation of abnormal involuntary DOI-induced head twitch response in male DBA/2J mice: I. Effects of D2/D3 and D2 dopamine receptor selective compounds. Rangel-Barajas C; Malik M; Vangveravong S; Mach RH; Luedtke RR Neuropharmacology; 2014 Aug; 83():18-27. PubMed ID: 24680675 [TBL] [Abstract][Full Text] [Related]
17. Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase. Haller VL; Stevens DL; Welch SP Eur J Pharmacol; 2008 Dec; 600(1-3):50-8. PubMed ID: 18762181 [TBL] [Abstract][Full Text] [Related]
18. Evidence that genetic variation in 5-HT transporter expression is linked to changes in 5-HT2A receptor function. Jennings KA; Sheward WJ; Harmar AJ; Sharp T Neuropharmacology; 2008 Apr; 54(5):776-83. PubMed ID: 18241894 [TBL] [Abstract][Full Text] [Related]
19. Involvement of diazepam-insensitive benzodiazepine receptors in the suppression of DOI-induced head-twitch responses in diabetic mice. Miyata S; Hirano S; Kamei J Psychopharmacology (Berl); 2006 May; 186(1):1-6. PubMed ID: 16555059 [TBL] [Abstract][Full Text] [Related]
20. Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice. Haller VL; Cichewicz DL; Welch SP Eur J Pharmacol; 2006 Sep; 546(1-3):60-8. PubMed ID: 16919265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]